Clinical Trials Logo

Clinical Trial Summary

A cluster randomized trial will be conducted to evaluate the difference between an Acteev™ system (Acteev™ N95 masks YQD8008 during shifts+ Acteev™ fabric masks in community) and a standard system (standard N95 masks during shifts+ fabric masks in community) in preventing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2)in healthcare workers(HCWs).


Clinical Trial Description

This is a maximum 10-week (8-week intervention+2-week follow up) (with the option of extending for another 4 weeks if needed) two-armed controlled study to investigate efficacy of Acteev™ system (Acteev™ N95 masks YQD8008 during shifts+ Acteev™ fabric masks in community) compared with standard system (standard N95 masks during shifts+ fabric masks in community) in HCWs working in high-risk hospital wards (ICU, emergency), against the prevention of SARS CoV-2 infection. Prospective HCWs will be identified for the study by the study investigator/study team and be invited for participation in the study. All study procedures will begin only after obtaining written informed consent from the subjects. Subjects will be randomized in one of the two arms mentioned below after meeting all the study eligibility criteria: Arm 1:Acteev™ system (Acteev™ N95 masks YQD8008 during shifts+ Acteev™ fabric masks in community) Arm 2: Standard system (standard N95 masks during shifts+ fabric masks in community). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05036941
Study type Interventional
Source Ascend Performance Materials
Contact Neelambari Bhosale
Phone +91-9823783443
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date September 2021
Completion date December 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04570904 - Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
Not yet recruiting NCT04525118 - Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform
Completed NCT04043923 - Norketotifen for the Treatment of Uncomplicated Influenza-like Illness Phase 2
Active, not recruiting NCT03965195 - Recombinant Influenza Vaccination in U.S. Nursing Homes Phase 4
Recruiting NCT04610047 - Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness Phase 2
Completed NCT04245800 - Home Testing of Respiratory Illness
Recruiting NCT05012189 - Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks Phase 4
Not yet recruiting NCT04716543 - Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals
Completed NCT04320862 - COVID-19 Pandemic Response Network